CareDx CDNA Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -8.1%-20.3pp | 12.2%+84.8pp | -72.5%-48.5pp | -24%-14.0pp | |
| Net margin | -5.6%-21.4pp | 15.7%+83.6pp | -67.9%-44.1pp | -23.8%-13.5pp | |
| EBITDA margin | -4.2%-20.6pp | 16.5%+83.9pp | -67.4%-47.0pp | -20.4%-13.3pp | |
| Returns | |||||
| Return on equity | -6.3%-22.7pp | 16.4%+71.4pp | -55%-37.9pp | -17.1%-8.8pp | |
| Return on assets | -4.7%-15.7pp | 11%+48.7pp | -37.7%-23.9pp | -13.8%-7.3pp | |
| Return on invested capital | -11.1%-27.2pp | 16.1%+84.7pp | -68.7%-38.9pp | -29.8%-10.0pp | |
| Efficiency | |||||
| Asset turnover | 0.8×+0.1× | 0.7×+0.1× | 0.6×0.0× | 0.6×-0.1× | |
| Liquidity | |||||
| Current ratio | 2.9×-1.1× | 3.9×-0.1× | 4×-1.1× | 5.1×-0.5× | |
| Quick ratio | 2.6×-1.2× | 3.7×-0.1× | 3.8×-1.1× | 4.9×-0.5× | |
| Cash ratio | 0.7×-0.6× | 1.3×+0.2× | 1.1×-0.1× | 1.2×-3.3× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0.1×-0.1× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -3.4×-6.8× | 3.5×+20.6× | -17.1×+3.4× | -20.5×+165× | |
| Per Share | |||||
| Book value per share | $5.69-14.9% | $6.68+37.5% | $4.86-39.9% | $8.08-9.4% | |
| Valuation | |||||
| Market capitalization | $1.4B+32.2% | $1.15B+76.9% | $649.18M+6.3% | $610.86M-74.6% | |
| Enterprise value | $1.35B+34.6% | $1.06B+76.7% | $600.62M+7.4% | $559.41M-73.0% | |
| Price / sales | 3.4×+0.3× | 3.4×+1.1× | 2.3×+0.4× | 1.9×-6.2× | |
| Price / book | 4.5×+1.7× | 3×+0.6× | 2.5×+1.1× | 1.4×-3.7× | |
| EV / sales | 3.3×+0.4× | 3.2×+1.0× | 2.1×+0.4× | 1.7×-5.3× | |
| Earnings yield | -0.6%-6.4pp | 4.6%+33.9pp | -29.3%-16.8pp | -12.5%-11.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CareDx's profit margins?
- CareDx (CDNA) runs a 65.5% gross margin and a -3.9% operating margin, with a -2.0% net margin.
- Where do CareDx's ratios come from?
- Every ratio is computed from CareDx's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
